Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass

Preliminary results with the perventricular technique

Zahid Amin, David A. Danford, John Lof, Kim F. Duncan, Stacev Froemming, Emile A. Bacha, Ross M. Ungerleider, Marian Zembala, Carlos J. Troconis

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: In infants undergoing closure of perimembranous ventricular septal defects, cardiopulmonary bypass remains one of the factors that prolongs hospital stay and morbidity. A new technique was used to close the defects under echocardiographic guidance without cardiopulmonary bypass to prevent the deleterious effects of bypass. Methods: Recently, the Amplatzer membranous ventricular septal defect device (AGA Medical Corp, Golden Valley, Minn) was introduced. The device has a double-disc design with a short connecting waist. The left ventricular disc has an eccentric design to prevent encroachment on the aortic valve leaflets. Eight Yucatan miniature pigs with naturally occurring perimembranous ventricular septal defects underwent closure of the defect in the operating room by using the perventricular technique. After median sternotomy, a purse-string suture was placed on the free wall of the right ventricle. An angiocatheter was advanced in the right ventricle, and through the catheter, a wire was advanced from the right ventricle through the ventricular septal defect into the left ventricle. A delivery sheath and the dilator were advanced over the wire. The wire and catheter were removed, and appropriately sized Amplatzer membranous device was advanced through the sheath. The device was deployed under echocardiographic guidance with the heart beating. Results: The procedure was successful in all animals. There was no incidence of device embolization, heart block, or aortic insufficiency. Angiograms at 3 and 6 months revealed no residual defects and no aortic insufficiency. Pathologically, the devices were completely endothelialized when examined grossly. Conclusions: The perventricular technique appears to be excellent for closure of perimembranous ventricular septal defects in the operating room. The technique might be feasible in smaller babies, who are high-risk candidates for closure in the catheterization laboratory. Cardiopulmonary bypass and prolonged hospital stay are avoided.

Original languageEnglish (US)
Pages (from-to)234-241
Number of pages8
JournalJournal of Thoracic and Cardiovascular Surgery
Volume127
Issue number1
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Ventricular Heart Septal Defects
Cardiopulmonary Bypass
Equipment and Supplies
Heart Ventricles
Operating Rooms
Length of Stay
Catheters
Heart Block
Sternotomy
Aortic Valve
Catheterization
Sutures
Angiography
Swine
Morbidity
Incidence

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass : Preliminary results with the perventricular technique. / Amin, Zahid; Danford, David A.; Lof, John; Duncan, Kim F.; Froemming, Stacev; Bacha, Emile A.; Ungerleider, Ross M.; Zembala, Marian; Troconis, Carlos J.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 127, No. 1, 01.01.2004, p. 234-241.

Research output: Contribution to journalArticle

Amin, Zahid ; Danford, David A. ; Lof, John ; Duncan, Kim F. ; Froemming, Stacev ; Bacha, Emile A. ; Ungerleider, Ross M. ; Zembala, Marian ; Troconis, Carlos J. / Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass : Preliminary results with the perventricular technique. In: Journal of Thoracic and Cardiovascular Surgery. 2004 ; Vol. 127, No. 1. pp. 234-241.
@article{17a2a7f9ab4b4aa7bfc701219033bb00,
title = "Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: Preliminary results with the perventricular technique",
abstract = "Objective: In infants undergoing closure of perimembranous ventricular septal defects, cardiopulmonary bypass remains one of the factors that prolongs hospital stay and morbidity. A new technique was used to close the defects under echocardiographic guidance without cardiopulmonary bypass to prevent the deleterious effects of bypass. Methods: Recently, the Amplatzer membranous ventricular septal defect device (AGA Medical Corp, Golden Valley, Minn) was introduced. The device has a double-disc design with a short connecting waist. The left ventricular disc has an eccentric design to prevent encroachment on the aortic valve leaflets. Eight Yucatan miniature pigs with naturally occurring perimembranous ventricular septal defects underwent closure of the defect in the operating room by using the perventricular technique. After median sternotomy, a purse-string suture was placed on the free wall of the right ventricle. An angiocatheter was advanced in the right ventricle, and through the catheter, a wire was advanced from the right ventricle through the ventricular septal defect into the left ventricle. A delivery sheath and the dilator were advanced over the wire. The wire and catheter were removed, and appropriately sized Amplatzer membranous device was advanced through the sheath. The device was deployed under echocardiographic guidance with the heart beating. Results: The procedure was successful in all animals. There was no incidence of device embolization, heart block, or aortic insufficiency. Angiograms at 3 and 6 months revealed no residual defects and no aortic insufficiency. Pathologically, the devices were completely endothelialized when examined grossly. Conclusions: The perventricular technique appears to be excellent for closure of perimembranous ventricular septal defects in the operating room. The technique might be feasible in smaller babies, who are high-risk candidates for closure in the catheterization laboratory. Cardiopulmonary bypass and prolonged hospital stay are avoided.",
author = "Zahid Amin and Danford, {David A.} and John Lof and Duncan, {Kim F.} and Stacev Froemming and Bacha, {Emile A.} and Ungerleider, {Ross M.} and Marian Zembala and Troconis, {Carlos J.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.jtcvs.2003.08.023",
language = "English (US)",
volume = "127",
pages = "234--241",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass

T2 - Preliminary results with the perventricular technique

AU - Amin, Zahid

AU - Danford, David A.

AU - Lof, John

AU - Duncan, Kim F.

AU - Froemming, Stacev

AU - Bacha, Emile A.

AU - Ungerleider, Ross M.

AU - Zembala, Marian

AU - Troconis, Carlos J.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Objective: In infants undergoing closure of perimembranous ventricular septal defects, cardiopulmonary bypass remains one of the factors that prolongs hospital stay and morbidity. A new technique was used to close the defects under echocardiographic guidance without cardiopulmonary bypass to prevent the deleterious effects of bypass. Methods: Recently, the Amplatzer membranous ventricular septal defect device (AGA Medical Corp, Golden Valley, Minn) was introduced. The device has a double-disc design with a short connecting waist. The left ventricular disc has an eccentric design to prevent encroachment on the aortic valve leaflets. Eight Yucatan miniature pigs with naturally occurring perimembranous ventricular septal defects underwent closure of the defect in the operating room by using the perventricular technique. After median sternotomy, a purse-string suture was placed on the free wall of the right ventricle. An angiocatheter was advanced in the right ventricle, and through the catheter, a wire was advanced from the right ventricle through the ventricular septal defect into the left ventricle. A delivery sheath and the dilator were advanced over the wire. The wire and catheter were removed, and appropriately sized Amplatzer membranous device was advanced through the sheath. The device was deployed under echocardiographic guidance with the heart beating. Results: The procedure was successful in all animals. There was no incidence of device embolization, heart block, or aortic insufficiency. Angiograms at 3 and 6 months revealed no residual defects and no aortic insufficiency. Pathologically, the devices were completely endothelialized when examined grossly. Conclusions: The perventricular technique appears to be excellent for closure of perimembranous ventricular septal defects in the operating room. The technique might be feasible in smaller babies, who are high-risk candidates for closure in the catheterization laboratory. Cardiopulmonary bypass and prolonged hospital stay are avoided.

AB - Objective: In infants undergoing closure of perimembranous ventricular septal defects, cardiopulmonary bypass remains one of the factors that prolongs hospital stay and morbidity. A new technique was used to close the defects under echocardiographic guidance without cardiopulmonary bypass to prevent the deleterious effects of bypass. Methods: Recently, the Amplatzer membranous ventricular septal defect device (AGA Medical Corp, Golden Valley, Minn) was introduced. The device has a double-disc design with a short connecting waist. The left ventricular disc has an eccentric design to prevent encroachment on the aortic valve leaflets. Eight Yucatan miniature pigs with naturally occurring perimembranous ventricular septal defects underwent closure of the defect in the operating room by using the perventricular technique. After median sternotomy, a purse-string suture was placed on the free wall of the right ventricle. An angiocatheter was advanced in the right ventricle, and through the catheter, a wire was advanced from the right ventricle through the ventricular septal defect into the left ventricle. A delivery sheath and the dilator were advanced over the wire. The wire and catheter were removed, and appropriately sized Amplatzer membranous device was advanced through the sheath. The device was deployed under echocardiographic guidance with the heart beating. Results: The procedure was successful in all animals. There was no incidence of device embolization, heart block, or aortic insufficiency. Angiograms at 3 and 6 months revealed no residual defects and no aortic insufficiency. Pathologically, the devices were completely endothelialized when examined grossly. Conclusions: The perventricular technique appears to be excellent for closure of perimembranous ventricular septal defects in the operating room. The technique might be feasible in smaller babies, who are high-risk candidates for closure in the catheterization laboratory. Cardiopulmonary bypass and prolonged hospital stay are avoided.

UR - http://www.scopus.com/inward/record.url?scp=0742288436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0742288436&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2003.08.023

DO - 10.1016/j.jtcvs.2003.08.023

M3 - Article

VL - 127

SP - 234

EP - 241

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -